Trastuzumab (INN; trade names Herclon, Herceptin) is a monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain breast cancers. The HER receptors are proteins that are embedded in the cell membrane and communicate molecular signals from outside the cell (molecules called EGFs) to inside the cell, and turn ge...
Found on
http://en.wikipedia.org/wiki/Trastuzumab
Also called Herceptin. A targeted therapy used to treat HER2 positive breast cancer, and one of a group of drugs called monoclonal antibodies.
Found on
http://www.breastcancercare.org.uk/breast-cancer-information/glossary
A monoclonal antibody that binds to HER2 (human epidermal growth factor receptor 2), and can kill HER2-positive cancer cells. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Trastuzumab is used to treat breast cancer that is HER2-positive and has spread after treatment with...
Found on
http://www.cancer.gov/dictionary?expand=T
(tras-tuz´u-mab) a monoclonal antibody that binds to a protein overexpressed in some breast cancers; used as an antineoplastic agent in treatment of metastatic breast cancer with such overexpression.
Found on
http://www.encyclo.co.uk/local/21001
No exact match found.
